KFAS
TMDX icon

Keating Financial Advisory Services’s Transmedics TMDX Stock Holding History

Keating Financial Advisory Services’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13K Sell
32
-13
-29% -$1.1K ﹤0.01% 1928
2026
Q1 		$4.47K Buy
45
+32
+246% +$4.17K ﹤0.01% 1501
2025
Q4 		$1.58K Buy
+13
New +$1.63K ﹤0.01% 1658

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Keating Financial Advisory Services's TMDX Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its Transmedics (TMDX) stake by 29% in Q2 2026, selling an estimated $1.1K and leaving 32 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Keating Financial Advisory Services first reported a position in TMDX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.47K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Keating Financial Advisory Services held 32 shares of Transmedics worth $2.13K as of Q2 2026.
  • Keating Financial Advisory Services sold 13 Transmedics shares in Q2 2026, an estimated $1.1K.
  • Transmedics made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1928 holding.
  • Keating Financial Advisory Services first reported a position in Transmedics in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Transmedics position peaked at $4.47K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.